Novartis AG
Novartis AG (NOVN.SW) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NOVN.SW · as of Jun 9, 2026
Key Statistics
Explore Novartis AG Data
novn.sw stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 25.0%
Competitors & Peers
novn.sw competitorsNOVN.SW
ABT.SW
CLTN.SW
COPN.SW
GALE.SW
ROG.SWStock Performance
Full HistoryAbout Novartis AG
Novartis AG is a global pharmaceutical company dedicated to the discovery, development, production, and commercialization of a broad spectrum of healthcare solutions. Its business operations are segme…
what is novartis ag · novn.sw stock overview · novartis ag company profile · who is novartis ag ceo · novn.sw SIX · novartis ag headquarters · novartis ag business segments
About Stock Overview & Key Data
Novartis AG (NOVN.SW) is a Healthcare company in the Drug Manufacturers - General industry, listed on SIX since Aug 3, 1995. As of the latest trading session, NOVN.SW stock price is $117.04, with a market capitalization of $223.3B. The stock has returned +19.95% over the past 12 months and +7.87% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Novartis AG stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Novartis AG reported revenue of $57.1B and net income of $14.6B. For detailed data — including Novartis AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novartis AG (NOVN.SW) stock price is $117.04. The stock is traded on SIX under the ticker symbol NOVN.SW. The 52-week range is $91.20 – $131.00.